
Waltra-P 37.5mg/325mg Tablet
Marketer
Walton Healthcare Pvt. Ltd
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Waltra-P 37.5mg/325mg Tablet
Combiflam 37.5mg/325mg tablets provide dual pain relief for moderate to severe discomfort. Dosage and treatment length should strictly adhere to your physician's instructions. This medication can be taken with or without food; however, if stomach upset occurs, consume it with a meal. Consistent dosing is crucial; discontinue use only upon your doctor's recommendation. Potential side effects include nausea, vomiting, dry mouth, dizziness, and constipation, generally mild and transient. Report any rash or allergic response immediately. Pregnant individuals, those planning pregnancy, or breastfeeding mothers should consult their doctor before use.
Uses of Waltra-P 37.5mg/325mg Tablet
Significant to intense pain
Major Benefits of Waltra-P 37.5mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Waltra-P 37.5mg/325mg tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
Common Side effects of Waltra-P 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Waltra-P 37.5mg/325mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Waltra-P 37.5mg/325mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Waltra-P 37.5mg/325mg Tablet works:
Each Waltra-P 37.5mg/325mg tablet combines tramadol and paracetamol to effectively manage intense pain. Tramadol, an opioid analgesic, diminishes pain sensation by interrupting pain signals to the brain. Paracetamol acts by inhibiting the production of pain-inducing chemical substances.
SAFETY ADVICE
AlcoholUNSAFE
Combining Waltra-P 37.5mg/325mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Waltra-P 37.5mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Waltra-P 37.5mg/325mg tablets appear compatible. Available data from humans indicates minimal infant risk. However, seek medical advice promptly if your baby exhibits excessive drowsiness, feeding difficulties, respiratory distress, or hypotonia.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Waltra-P 37.5mg/325mg tablets.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Waltra-P 37.5mg/325mg tablets. Dosage modification of Waltra-P 37.5mg/325mg tablets may be necessary. Medical advice is recommended.
LiverCAUTION
Patients with liver impairment should use Waltra-P 37.5mg/325mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Waltra-P 37.5mg/325mg tablets are contraindicated for individuals experiencing severe or active liver disease.
What if you forget to take Waltra-P 37.5mg/325mg Tablet :
Should you forget to take your Waltra-P 37.5mg/325mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Waltra-P 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
